FIELD: experimental medicine.
SUBSTANCE: invention can be used to simulate delayed fetal development. A primigravida female aged 5–8 months, weighing 150–200 g, from the first day of pregnancy for 20 days twice a day, in the morning and in the evening, is fed with 15 g of dry food for rodents. During the first 14 days of the experiment, the morning and evening diets include a mixture containing 0.5 mg of Duphaston powder and 10 g of semolina.
EFFECT: invention improves the reproducibility of the fetal growth retardation model, which has clinical signs that are as similar as possible to the clinical picture in patients, and eliminates fetal miscarriage.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SIMULATING GESTATIONAL PYELONEPHRITIS | 2013 |
|
RU2532402C1 |
| METHOD FOR CORRECTION OF PULMONARY HYPOPLASIA IN FETUS CONGENITAL DIAPHRAGMATIC HERNIA IN RATS USING SELECTIVE INHIBITOR OF SPECIFIC PDE-5 CGMP | 2022 |
|
RU2801604C1 |
| METHOD FOR PREDICTING NEWBORN WEIGHT IN PREGNANT WOMEN WITH PREECLAMPSIA IN COMBINATION WITH FETAL GROWTH RETARDATION SYNDROME | 2020 |
|
RU2741861C1 |
| METHOD FOR PREVENTING PATHOLOGICAL PREGNANCY SYNDROME | 2015 |
|
RU2575789C1 |
| METHOD OF PREECLAMPSIA PREVENTION IN PREGNANT WOMEN WITH MUTATION OF FACTOR V LEIDEN 1691 G/A | 2017 |
|
RU2666251C1 |
| METHOD FOR PREDICTION OF NEWBORN'S WEIGHT IN PREGNANT WOMEN WITH PRE-ECLAMPSIA AND A FAMILY HISTORY OF PRE-ECLAMPSIA | 2020 |
|
RU2738685C1 |
| METHOD FOR PREDICTING THE RISK OF FETAL GROWTH RETARDATION SYNDROME IN THE 1ST TRIMESTER | 2021 |
|
RU2775344C1 |
| METHOD FOR PREDICTING EARLY FETAL GROWTH RETARDATION ACCORDING TO PLACENTOMETRY AT 19-21 WEEKS OF GESTATION IN LOW-RISK PATIENTS | 2022 |
|
RU2795084C1 |
| METHOD FOR PREDICTING THE RISK OF FETAL GROWTH RETARDATION | 2021 |
|
RU2775435C1 |
| PREDICTION OF PLACENTAL PREECLAMPSIA ACCORDING TO PLACENTOMETRY AT GESTATION 19-21 WEEKS IN LOW-RISK PATIENTS | 2021 |
|
RU2771762C1 |
